Zidovudine could cut transmission of HIV by mothersBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6929.614 (Published 05 March 1994) Cite this as: BMJ 1994;308:614
- J Roberts
Zidovudine reduces the risk of mothers who are HIV positive transmitting the virus to their fetuses by two thirds, according to preliminary results of a multicentre clinical trial. The trial was sponsored by the US National Institutes of Health and the French Agence Nationale de Recherches sur le SIDA.
The study, in which 59 centres participated, was stopped early when analysis of data showed a transmission rate of 8.3% when both mothers and their babies received zidovudine compared with a rate …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial